These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31857033)

  • 1. First-in-Human Study of Paclitaxel Drug-Coated Chocolate Coronary Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in De Novo Coronary Artery Lesions.
    Garcia-Lithgow C; Tirziu D; Zhou S; Bouras G; Shah T; Grubman D; Javier JJ; Mustapha JA; Abizaid A; Lansky AJ
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2568-2570. PubMed ID: 31857033
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Chung JH; Shin ES; Her AY; Lee JM; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):179-185. PubMed ID: 31598811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels: initial experience with the Essential paclitaxel-coated balloon.
    Abellas-Sequeiros RA; Benezet J; Agarrado Luna A; Oneto Otero J; Déry JP; Cieza T; DeLarochellière R; Duocastella L; Gomez A; Molina M; Asmarats L; Pelletier-Beaumont E; Puri R; Rodés-Cabau J
    Coron Artery Dis; 2018 Sep; 29(6):477-481. PubMed ID: 29621009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Uskela S; Kärkkäinen JM; Eränen J; Siljander A; Mäntylä P; Mustonen J; Rissanen TT
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):893-900. PubMed ID: 30380186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease.
    Yerasi C; Case BC; Forrestal BJ; Kolm P; Dan K; Torguson R; Weintraub WS; Garcia-Garcia HM; Waksman R
    Cardiovasc Revasc Med; 2020 Apr; 21(4):549-555. PubMed ID: 32317227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.
    Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis.
    Rhee TM; Lee JM; Shin ES; Hwang D; Park J; Jeon KH; Kim HL; Yang HM; Han JK; Park KW; Hahn JY; Koo BK; Kim SH; Kim HS
    JACC Cardiovasc Interv; 2018 May; 11(10):969-978. PubMed ID: 29798774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
    Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
    Kleber FX; Schulz A; Waliszewski M; Hauschild T; Böhm M; Dietz U; Cremers B; Scheller B; Clever YP
    Clin Res Cardiol; 2015 Mar; 104(3):217-25. PubMed ID: 25349065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
    Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis.
    Pleva L; Kukla P; Zapletalova J; Hlinomaz O
    BMC Cardiovasc Disord; 2017 Jun; 17(1):168. PubMed ID: 28651572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel paclitaxel-coated scoring ballon for de novo complex coronary lesions-first report.
    di Palma G; Cortese B
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):390-392. PubMed ID: 28923693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized trial of paclitaxel-coated balloon versus bare-metal stent in high bleeding risk patients with de novo coronary artery lesions.
    Shin ES; Lee JM; Her AY; Chung JH; Eun Lee K; Garg S; Nam CW; Doh JH; Koo BK
    Coron Artery Dis; 2019 Sep; 30(6):425-431. PubMed ID: 31009399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
    Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
    Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting balloons in the treatment of de-novo coronary lesions: a meta-analysis of randomized-controlled trials.
    Li Y; Wang C; Zuo G; Wang K; Cao Z; Du X
    Coron Artery Dis; 2016 Sep; 27(6):467-77. PubMed ID: 27100660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial.
    Claessen BE; Henriques JPS; Vendrik J; Boerlage-van Dijk K; van der Schaaf RJ; Meuwissen M; van Royen N; Gosselink ATM; van Wely MH; Dirkali A; Arkenbout EK; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):216-221. PubMed ID: 30232824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO).
    Latib A; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1132-1134. PubMed ID: 26205451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.